Post-translational modification of glutamine and lysine residues of HIV-1 aspartyl protease by transglutaminase increases its catalytic activity.
Post-translational modification of glutamine and lysine residues of HIV-1 aspartyl protease by transglutaminase increases its catalytic activity.
复制标题
通过转谷氨酰胺酶对 HIV-1 天冬氨酰蛋白酶的谷氨酰胺和赖氨酸残基进行翻译后修饰可增加其催化活性。
DOI:
10.1016/j.bbrc.2010.02.060
复制
发表时间:
2010
影响因子:
3.1
通讯作者:
S. Beninati
中科院分区:
文献类型:
--
作者:
A. Lentini;C. Tabolacci;S. Melino;B. Provenzano;S. Beninati
The human immunodeficiency virus type 1 aspartyl protease (HIV-1 PR) is a homodimeric aspartyl endopeptidase that is required for virus replication. HIV-1 PR was shown to act invitro as acyl-donor and -acceptor for both guinea pig liver transglutaminase (TG, EC 2.3.2.13) and human Factor XIIIa. These preliminary evidences suggested that the HIV-1 PR contains at least three TG-reactive glutaminyl and one lysyl residues. We report here that the incubation of HIV-1 PR with TG increases its catalytic activity. This increase is dependent upon the time of incubation, the concentration of TG and the presence of Ca2+. Identification of ε-(γ-glutamyl)lysine in the proteolytic digest of the TG-modified HIV-1 PR suggested intramolecular covalent cross-linking of this protease which may promote a non-covalent dimerization and subsequent activation of this enzyme via a conformational change. This hypothesis is supported by the observation that the TG-catalyzed activation of HIV-1 PR was completely abolished by spermidine (SPD) which acts as a competitive inhibitor of ε-(γ-glutamyl)lysine formation. Indeed, in the presence of 1mM SPD the formation of the isopeptide was decreased of about 80%. The main products of the TG-catalyzed modification of HIV-1 PR in the presence of SPD were N1-mono(γ-glutamyl)SPD and N8-mono(γ-glutamyl)SPD. Negligible amount of N1,N8-bis(γ-glutamyl)SPD were found. The significance of these results is discussed with respect to the activation of the protease by post-translational modification and design of potential inhibitors.
影响因子:
--
作者:
Davies,PJ;Chiocca,EA;Basilion,JP;Poddar,S;Stein,JP
通讯作者:
Stein,JP
影响因子:
5.6
作者:
M. Todd;N. Semo;E. Freire
通讯作者:
M. Todd;N. Semo;E. Freire